| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| PSCA | HOT PSA-H52H6 | Human PSCA Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $470.00 100ug | ||
| PSCA | HOTAvitag PSA-H82E3 | Biotinylated Human PSCA Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $415.00 25ug | ||
| PSCA | Alexa Fluor™ 488-Labeled Human PSCA Protein, His Tag (Site-specific conjugation) | Human | HEK293 | ![]() | $415.00 25tests | ||||
| PSCA | PE-Labeled Human PSCA Protein, His Tag (Site-specific conjugation) | Human | HEK293 | ![]() | $415.00 25tests | ||||
| PSCA | Avitag PSA-M82Ea | Biotinylated Mouse PSCA Protein, His,Avitag™ (MALS verified) | Mouse | HEK293 | ![]() | MALS | $710.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes (City of Hope Medical Center) | Phase 1 Clinical | City Of Hope National Medical Center | Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant | Details | |
| 124-iodine-labeled PSCA targeting minibody (ImaginAb) | Phase 1 Clinical | University Of California At Los Angeles | Pancreatic Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms | Details | |
| anti-PSMA/anti-PSCA CAR T-cell therapy PD-1 silent (Shanghai Unicar-Therapy Bio-medicine) | Phase 1 Clinical | Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd | Hormone-Resistant Prostate Neoplasms | Details | |
| MB-104 | MB-104; MB-105; MB-104 CS1 CAR; MB-105 PSCA CAR | Phase 1 Clinical | City Of Hope National Medical Center | Glioblastoma; Multiple Myeloma; Pancreatic Neoplasms; Prostatic Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | Details |